FDA panel on the use of antidepressants during pregnancy is alarming experts
By Corinne Purtill, Los Angeles Times LOS ANGELES — The U.S. Food and Drug Administration is turning its attention to selective serotonin reuptake inhibitors, a class of antidepressant drugs long criticized by Health and Human Services Secretary Robert F. Kennedy … Continued